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METHOD AND APPARATUS FOR A 
MINIATURE BIOREACTOR SYSTEM FOR 
LONG-TERM CELL CULTURE 
RELATED APPLICATIONS 
This application claims priority to U.S. Provisional Patent 
Application Ser. No. 60/819,325, filed 7 Jul. 2006 (Jul. 7, 
2006), incorporated herein by reference. 
GOVERNMENT INTEREST 
Some of the subject matter disclosed in this application was 
funded to some degree by funds supplied by the United States 
Government under NASA contract no. 9930-288-01 NCC 
9-142. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present invention relates to a bioreactor apparatus for 
producing cells, selectively harvesting cells and/or tissues, 
and/or studying cells and/or tissues in vitro under different 
conditions over short or long time periods, and methods for 
making and using same. 
More specifically, the invention relates to a bioreactor 
apparatus for producing cells, selectively harvesting cells 
and/or tissues, and/or studying cells and/or tissues in vitro 
under different conditions over short or long time periods, 
where the apparatus includes a laminar flow chamber having 
a plurality of cell proliferation zones, each zone having an 
associated inlet and outlet. The apparatus also includes a fluid 
handling system and a gas handling system, where the two 
systems are adapted to seed or inoculate, feed, gasify, harvest, 
stress, and/or study cells over short or long time periods. The 
apparatus can also include a housing containing the chamber 
and systems, where the housing includes pressure, tempera-
ture, humidity, etc., control systems. The apparatus can 
include components for automated and unmanned cell seed-
ing, cell proliferating, cell stressing, cell harvesting and cell 
monitoring operations under antiseptic conditions and for 
post harvesting analysis, the apparatus can be associated with 
a cell fluid dynamic/analysis system, especially a micro-flu-
idic cell handling and analyzing system. The invention also 
relates to methods for making and using same. 
2. Description of the Related Art 
Reliable and efficient cell production is now the central 
focus in the growing demand for drug development and test-
ing, the creation of artificial organs, the creation of engi-
neered tissue, the production of active proteins made by 
genetically engineered cells, the production of hormones, 
antibodies, or enzymes, the preparation of viral vaccines, and 
the advanced understanding of biological processes. Addi-
tionally, efforts have been directed to the understanding of 
cell growth and behavior upon exposure to stressors, cell-to-
cell biocompatibility, tissue healing processes, cell and tissue 
toxicity, cell apoptosis, cell and tissue chemotaxis, and cell 
and tissue mechanotaxis. Some of these studies require the 
simultaneous production of cell cultures within the same 
bioreactor and in a parallel fashion. 
One of the crucial problems associated with cell produc-
tion is that it is time consuming, expensive, and requires 
skilled operators. To overcome these barriers, some attempts 
have been made to manufacture bioreactors and develop 
methods for optimizing cell production and for studying cell 
chemotaxis and mechanotaxis. 
U.S. Pat. No. 5,153,131 (Wolf et al.) discloses a suspension 
cell culture system where a culture chamber is rotatable about 
a horizontal axis and has a vertical large area oxygen trans-
missible membrane spaced a distance about 0.25 inches less 
5 than 1.0 inches from a facing vertical wall surface for effec-
tive transmission of oxygen to cells in suspension in the 
culture chamber. The facing vertical wall surface can be a 
dialysis membrane for exchange of fresh nutrient from a 
dialysis chamber with cell waste product in the culture cham- 
10 ber. 
U.S. Pat. No. 5,496,722 (Goodwin et al.) disclosed a nor-
mal mammalian tissue and the culturing process has been 
developed for the three groups of organ, structural and blood 
tissue. The cells are grown in vitro under microgravity culture 
15 conditions and form three dimensional cells aggregates with 
normal cell function. The microgravity culture conditions 
may be microgravity or simulated microgravity created in a 
horizontal rotating wall culture vessel. 
U.S. Pat. No. 5,763,279 (Schwarz et al.) disclosed an appa- 
20 ratus and method of use for a new simply constructed biore-
actor made at least partially of gas permeable materials. The 
bioreactor is useful for culturing cells and tissues in suspen-
sion in a liquid nutrient medium with minimum turbulence. 
The bioreactormay include ports for easy access to the vessel 
25 culture, allowing the growth substrate to be varied for opti-
mum performance. A method for culturing cells using the 
disclosed bioreactor is also described. 
U.S. Pat. No. 6,867,040 B2 (Helmstetter et al.) disclosed an 
apparatus and methods directed to a perfusion culture system 
30 in which a rotating bioreactor is used to grow cells in a liquid 
culture medium, while these cells are attached to an adhesive-
treated porous surface. As a result of this arrangement and its 
rotation, the attached cells divide, with one cell remaining 
attached to the substrate, while the other cell, a newborn cell 
35 is released. These newborn cells are of approximately the 
same age, that are collected upon leaving the bioreactor. The 
populations of newborn cells collected are of synchronous 
and are minimally, if at all, disturbed metabolically. 
Thus, there is a need in the art for an improved bioreactor 
40 apparatus for perfusing cells with a medium; controlling an 
amount of fresh and/or recirculated medium through inlet 
valves supplying medium to each laminar zone in the biore-
actor apparatus; controlling waste collection through an out-
let valve; controlling temperature, gas transport, gas 
45 exchange, and humidity; inoculating cells through an inocu-
lation port; sampling/assaying cells, supernatant, and cell 
products; selectively harvesting cells; and selectively harvest-
ing cell products. 
50 	 SUMMARY OF THE INVENTION 
Apparatuses 
The apparatus of the present invention provides a laminar 
flow bioreactor apparatus including a laminar flow cell cul- 
55 ture assembly including a laminar flow chamber having a 
plurality of cell proliferation zones. Each zone is adapted to 
support cell proliferation. In embodiments involving the use 
of anchorage cells, each zone includes at least one surface 
comprising a substrate conducive to cell growth and where 
60 each zone includes an inlet and an outlet. However, the sub-
strate can also be a test substrate to determine anchorage 
propensity, anchorage antagonism, or other substrate effects 
on cell inoculation, proliferation, harvesting, etc. Each inlet 
includes a fluid diffuser and each outlet includes a fluid col- 
65 lector. 
The apparatus also includes a fluid handling system, where 
the system supplies medium and/or gas to the zones at a 
US 9,023,642 B2 
3 
medium flow rate and at a gas concentration sufficient to 
maintain laminar flow throughout the zones and sufficient to 
support cell proliferation throughout the zones. In certain 
embodiments, the chamber has a volume of about 1 mL. In 
other embodiments, the chamber has a volume less than 1 mL. 
However, the volume of the chamber can be adjusted to any 
desired volume, provided that laminar flow is maintained in 
each of the zones and sufficient gas transport and exchange 
can occur throughout the zones to maintain all the cells in 
each zone under substantially the same conditions. It should 
be recognized that each zone can be supplied with different 
media and different gases. The zones are adapted to support 
single cell layers growing on the conducive substrate or to 
support multiple cells layer, where a first layer is seeded and 
proliferated onto the conducive substrate and each additional 
layer deposited onto the previously proliferated layer or to 
support the preparation of a layer made of a plurality of 
different cell types, where a first cell type is seeded and 
proliferated on the conducive substrate and one or more addi-
tional cell types are deposited so that the layer comprises a 
mixture of the cell types. Single cell layers having multiple 
cell types are ideally suited for studying the effects of stem 
cells on different cell lines or the effects of cancer cells on 
different cell lines. 
The apparatus can also include a plurality of laminar flow 
cell chambers and a more sophisticated fluid and gas handling 
system so that the medium flowing into each zone of each 
chamber can be the same or different and the cells from each 
zone of each chamber can be independently or collectively 
harvested and/or cell products from each zone of each cham-
ber can be independently or collectively collected. The appa-
ratus can also include a sealed and antiseptic housing with the 
bio-reactor apparatus disposed therein, where the housing 
includes temperature, pressure, gas, humidify, etc. controller. 
The fluid/gas handling system includes inlet valves, outlet 
valves, an inoculation port, and a cell sampling/assaying port, 
where the fluid handling system is adapted to perfuse cells in 
the each zone of each chamber with a medium, control an 
amount of the medium entering the each zone of each cham-
ber via the inlet valves, and control waste collection via the 
outlet valves. The fluid/gas handling system and the housing 
are adapted to control a temperature of the bioreactor appa-
ratus, a pressure in the housing, a humidity in the housing, a 
gas transport rate into each zone of each chamber, and a gas 
exchange rate in each zone of each chamber. The fluid/gas 
handling system is also adapted to inoculate the chamber with 
cells through the inoculation port, and to sample and assay 
cells, supernatants, and cell products through the sampling/ 
assaying port, to selectively harvest cells, and to selectively 
collect cell products. Each chamber is adapted to support a 
plurality of cell growth regions, where the regions separated 
one from the other without the need of a physical barrier such 
as a filters or wall. 
Bio-Sensors or Bio-Sentinels 
The present invention also provides a monitoring system 
including a bioreactor apparatus of this invention, where cells 
in the apparatus are used as bio-sensor or bio-sentinels to 
evidence hazardous conditions and to alter personnel in 
potentially hazardous environments of a hazardous condition 
such as a chemical, biological, physical, radiation, or other 
hazardous condition. 
Systems 
The present invention also provides a monitoring system 
including a bioreactor apparatus ofthis invention, where cells 
in the apparatus are exposed to oxygen deprivation, nutrient 
deprivation, toxins, pathogens and/or mutagenes while moni- 
4 
toring the response of the cells, such as mutations, death, 
retarded growth, uncontrolled growth, etc. 
Methods 
The present invention also provides a method including the 
5 steps of seeding, producing, and harvesting cells from a biore-
actor apparatus of this invention. The method can also include 
the step of studying cells in the bioreactor apparatus during 
seeding, producing or proliferating, harvesting and/or study-
ing cell seeding, producing or proliferating, and harvesting. 
10 The method can also include the step of monitoring cell 
seeding, producing or proliferating and harvesting, when 
exposing cells in the bioreactor apparatus to experimental 
conditions, where the experimental conditions can include 
changes in temperature, changes in pressure, changes in 
15 humidity, changes in buffers, changes in nutrients, changes in 
gases and gas mixtures, exposure to pharmaceuticals, expo-
sure to toxins, exposures to mutagenes, exposure to patho-
gens, or exposure to other harmful or stimulating conditions 
or additives. 
20 	 The present invention also provides a method including the 
steps of seeding, producing, studying and/or harvesting cells 
using a bioreactor apparatus of this invention. The bioreactor 
apparatus of this invention is ideally suited for studying: (1) 
cell chemotaxis, mechanotaxis, apoptosis, artificial organ, 
25 skin and other tissue growth, (2) cell production of active 
proteins, hormones, antibodies, or enzymes, (3) preparing 
viral vaccines, and (4) drug testing. The method can also 
include analyzing harvested or collected cells from the appa-
ratus using advanced analytical techniques, tools and equip- 
30 ments. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The invention can be better understood with reference to 
35 the following detailed description together with the appended 
illustrative drawings in which like elements are numbered the 
same. 
FIG. 1A depicts a block and flow diagram of an embodi-
ment of a bioreactor apparatus of the invention. 
40 	 FIG. 1B depicts a block and flow diagram of another 
embodiment of a bioreactor apparatus of the invention. 
FIGS. 2A&B depict a top view and a side view of an 
embodiment of a laminar flow chamber of this invention, 
respectively. 
45 FIG. 2C depicts a 3D rendering of the chamber of FIGS. 
2A&B. 
FIG. 2D is a photograph of the chamber of FIGS. 2A&B 
relative to a quarter. 
FIG. 2E depicts a top view of another embodiment of a 
50 laminar flow chamber of this invention having three laminar 
flow isolated zones. 
FIG. 2F depicts a top view of another embodiment of a 
laminar flow chamber of this invention four laminar flow 
isolated zones. 
55 FIGS. 3A&B depict a top and side view of an embodiment 
of a controlled gas chamber for use with the chamber of FIGS. 
2A&B. 
FIG. 4A depicts an assembly of the laminar flow cell cul-
ture chamber of FIGS. 2A&B and the gas chamber of FIGS. 
60 3A&B. 
FIG. 4B depicts a 3D rendering of the assembly of FIG. 4A. 
FIGS. 5A-C depict a top, front, and side views of an 
embodiment of an inlet valve of this invention. 
FIG. 5D depicts a 3D rendering of the inlet valve of FIGS. 
65 5A-C showing flow paths. 
FIGS. 6A-C depict a top, front, and side views of an 
embodiment of an outlet valve of the invention. 
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FIG. 6D depicts a 3D rendering of the outlet valve of FIGS. 
6A-C showing flow paths. 
FIG. 7 depicts an embodiment of a bioreactor apparatus of 
this invention including the assembly of FIG. 4A. 
FIG. 8 depicts another embodiment of a bioreactor appa-
ratus of this invention including a inline medium gasification 
assembly. 
FIG. 9A depicts a flow diagram of an embodiment of a 
method for using the bioreactor of this invention for short 
term cultures and studies. 
FIG. 9B depicts a flow diagram of an embodiment of a 
method for using the bioreactor of this invention for moderate 
and long term studies. 
FIG. 10A depicts a 
FIGS. 1OB&C depict an illustration of cell seeding and 
proliferating to form a monolayer in a laminar flow chamber 
of thi s invention or in reverse, an illustration of cell harvesting 
a monolayer from a laminar flow chamber of this invention. 
FIG. 10D depicts a simulation of flow lines or flow path-
lines within the zones of a chamber of FIG. 2A, one set of 
lines representing medium and the over representing protease 
concentration for releasing anchorage dependent cells from 
the zones. 
FIG. 11A-C depict a simulation sequence evidencing the 
establishment of a component gradient within a zone of a 
chamber of this invention. 
FIGS. 12A&B depict a simulation sequence evidencing 
wall shear stress levels produced within a chamber of this 
invention under normal working conditions. 
FIG. 13 depicts a schematic diagram of a microchip chan-
nel manifold for a cytometry microchip analyzer. 
FIG. 14A is a photomicrograph of a confluent monolayer 
of BHK-21 cells in a zone of an chamber of FIG. 2A. 
FIG. 14B depicts a photomicrograph of the zone after a 
selective harvesting of the cells in the zone. 
FIG. 15 depicts a cell number characterization study, 
where cell counts were determined via hemocytometer, Via-
Count, and microchip cytometry single point analysis of FIG. 
13. 
FIG. 16 is a photomicrograph of BHK-21 migration and 
re-population of the harvested zone of FIG. 14A over a 7 hour 
period 
FIG. 17 depicts a simulation of hypoxia exposure of fetal 
cardiomyocytes in one of the zones of a chamber of FIGS. 
2A&B. 
FIG. 18A-F depict microphotograph of a zone over a 72 
hour period of time evidencing inoculation and proliferation 
of fetal cardiomyocytes under working conditions. 
FIGS.I9A&B depict microphotograph of dye assay show-
ing live cells and apoptotic cells after 72 hours of Normoxia: 
A. Acridine orange stained cells viewed using a 490/530,640/ 
B, IB filter and B. Ethidium bromide stained cells viewed 
using a 545/605/G, IG filter. 
FIG. 20A-D depict microphotograph of dye assay showing 
results after 24 hours of hypoxia and reoxygenation: A. Acri-
dine orange stained cells viewed using a 490/530,640/B, IB 
filter and B. Ethidium bromide stained cells viewed using a 
545/605/G, IG filter. C. Merged images of A and B. D. Cell 
quantification. 
FIGS. 21A&B depict quantification studies after 24 hour 
hypoxia: A. normal zone and B. hypoxia zone after 24 hours 
of hypoxia. 
FIGS. 22A&B depict quantification studies after 24 hours 
reoxygenation: A. After 24 hours reoxygenation of normoxitc 
region and B. After 24 hours reoxygenation of hypoxic zone. 
6 
FIG. 23 depicts a plot of Canine Fetal Cardiomyocytes 
growth in the presence of Acridine Orange and Ethidium 
Bromide. 
5 	 DETAILED DESCRIPTION OF THE INVENTION 
The inventors have found that a bioreactor apparatus can be 
constructed that permits cell seeding or inoculation, cell pro-
duction, growth or proliferation and cell harvesting or cell 
to product collecting, where the apparatus includes a laminar 
flow assembly. The assembly includes a laminar flow cham-
ber having a plurality of cell growth regions or zones, where 
each zone is substantially separated without the need for 
15 physical separation elements such as a filter, a barrier, or the 
like. The chamber is constructed to take advantage of laminar 
flow of medium into, through and out of the regions or zones 
so that each laminar flow region or zone can be separately 
populated, manipulated, controlled, harvested, stressed, etc. 
20 without affecting the other regions. Of course, the chamber 
can be constructed to include an interaction zone between 
laminar flow zones, where two adjacent laminar regions come 
into contact. Because the chamber does not include a physical 
barrier, the chamber is ideally well suited for studying and 
25 monitoring interacts between adjacent laminar flow zones 
such as a monitoring chemical signaling between cells in 
adjacent laminar flow zones. 
The apparatus can also be used to continuously, semi-
continuously, periodically, or intermittently harvest cell in the 
30 independent regions. The apparatus can also be used for short 
term, moderate term, and long term proliferation and harvest-
ing of cells of a desired cell line or to study effects of additives 
on short, moderate or long term culture stability and prolif-
eration. Generally, cell harvesting occurs when proliferation 
35 in a zone does not exceed about 95%. In certain embodiments, 
harvesting occurs when proliferation is a zone does not 
exceed about 90%. In other embodiments, harvesting occurs 
when proliferation is a zone does not exceed about 85%. In 
certain embodiments, harvesting occurs when proliferation is 
4o a zone does not exceed about 80%. In certain embodiments, 
harvesting occurs when proliferation is a zone does not 
exceed about 75%. In certain embodiments, harvesting 
occurs when proliferation is a zone does not exceed about 
70%. Of course, the proliferation can be greater or smaller 
45 depending on the study being performed. It has been found 
that when proliferation approaches 100%, cultures stability 
so proliferation is often not taken to much over about 80% 
before harvesting. 
Apparatus 
50 	 The present invention broadly relates to an apparatus for 
producing, studying, harvesting, stressing, etc. cells over 
short, moderate or long periods of time, i.e., an apparatus for 
preparing short, moderate or long term cell cultures. In cer-
tain embodiments, the apparatus includes a sealed and anti- 
55 septic laminar flow cell assembly. The assembly includes one 
laminar flow chamber or a plurality of laminar glow cham-
bers. Each chamber includes a plurality of cell proliferation 
zones. The chamber includes at least one surface comprising 
a cell growth conducive substrate disposed on a top or a 
6o bottom of the chamber. The chamber can of course include 
cell growth conducive substrates on both the top and bottom 
of the chamber. Each zone in each chamber includes an inlet 
and an outlet. In most embodiment, each inlet includes a 
diffuser adapted to spread the flow lowering flow velocities as 
65 the flow enters the zone, and each outlet includes a collector 
adapted to reduce turbulent flow as fluid is removed from the 
zone through the outlet. 
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The apparatus also includes a fluid handling system. The 
fluid handling system includes a liquid handling or hydraulic 
system and a gas handling system. The liquid handling sys-
tem includes at least one inlet valve connected to the zone 
inlets and at least one outlet valve connected to the zone 
outlets, where the inlet valves controls fluid flow to the cham-
ber inlets and the outlet valves control fluid flow out of the 
chamber. The gas handling system includes a gas supply and 
regulator for regulating gas flow into the zones. The gas 
handling system can also include a gas chamber in gas com-
munication with the zones via a gas permeable membrane. 
The gas handling system can also include values and flow 
controllers adapted to introduce a gas at a given rate into the 
medium before or as it is pumped into the zones. The fluid 
handling system is adapted to perfuse the cells in the zones 
with a medium, to control an amount of spent (recirculated) 
medium and/or an amount of fresh medium through the inlet 
valve(s) into the zones, to control waste collection as spent 
medium (medium existing the zones) and passes through the 
outlet valve(s), to control temperature, to control gas trans-
port, to control gas exchange, and to control humidity. The 
system also includes an inoculation port for inoculating or 
seeding into the zones of each chamber. The apparatus can 
also included a sample and/or assay port for sampling or 
assaying cells in the zones, supernatant coming from the 
zones, and cell products from the cells in the zones. The 
apparatus can also be used for selectively harvest cells, and 
selectively collect cell products. 
The plurality of cell zones in each chamber are separated 
due to the structure of the chamber and the laminar flow 
maintained in each zone without the need for physical barriers 
such as filters or other type of physical barrier the zones are 
separated by laminar flow. Each zone of each chamber is 
configured for receiving a culture medium through its inlet 
and for releasing spent culture medium through its outlet. In 
most embodiments, the entering medium flow is spread by a 
diffuser and the exiting medium flow is spread by a collector. 
The inlets and outlets can also be used to introduce stressors, 
to introduce pathogens, to introduce toxins, to introduce 
mutagenes, etc., to harvest cells, to inoculate or seed cells, to 
inoculate other cell types into a stable or proliferating cell 
population, or to form multi-layered cell cultures. 
The miniature laminar flow bioreactor can be controlled 
with specially designed or commercial computer software 
through direct or wireless connections to allow selective 
seeding, proliferating, and/or harvesting of cells in each lami-
nar zone of each chamber under manual or automated/un-
manned control for short, moderate, or long term cell culture 
studies. 
In another embodiment, the bioreactor includes a gas 
chamber assembly disposed adjacent the gas permeable 
membrane forming the top or bottom of the chamber and 
adapted to control gas transport, gas exchange and/or humid-
ity in each zone of the chamber. In most embodiments, the gas 
chamber assembly supplies a single gas composition to each 
zone of the chamber, the gas chamber assembly can be par-
titioned so that each zone is exposed to a different gas com-
position to study diffusion of gas from one laminar flow zone 
to an adjacent laminar flow zone via an interaction zone 
between the zone, which can be designed to be of a desired 
volume. 
In another embodiment, the bioreactor is used to grow 
suspension cells, anchorage dependent cells, and/or stem 
cells under controlled conditions designed to grow, harvest 
and/or study such cells over the short, moderate or long term. 
In another preferred embodiment, each chamber can 
simultaneously support the same or different cell population 
8 
within each zone, where the zones are laminar flow isolated 
except for a small and controlled interaction volume at a 
portion of the chamber where the laminar flow lines in one 
zone are substantially parallel to the laminar flow lines in an 
5 adjacent zone. 
In another embodiment, the laminar flow cell culture 
chamber is sealed to keep gas exchange level at its optimum. 
In another embodiment, the laminar flow cell culture 
chamber is sterilized to minimize external contamination of 
cells growing within the zone during short, moderate and/or 
10 long term cell culture studies, where the and/or means that 
one zone could support a short term culture, while an adjacent 
zone could support a moderate or long term culture or any 
other combination of short, moderate or long term studies. 
In another embodiment, the laminar flow cell culture 
15 chamber is made of optically transparent walls allowing the 
device to be used as bench top device sitting on a microscope 
for the live observation of cell growth and cell behavior upon 
exposed stressors such as chemical, physical, and/or biologi-
cal stressors. 
20 	 In another embodiment, the laminar flow cell culture 
chamber is coupled with an automated fluid handling system 
through the inlet and exit valves to control and regulate the 
perfusion of cells with media, nutrients, saline wash or 
enzyme treatment, growth factors, drug, hormone, chemot- 
25 axis agents, and other substances. In yet another embodiment, 
the automatic fluid handling system insures the selective har-
vesting or removal of cells over time to prevent cells from 
becoming over confluent with dynamic manipulation. 
In another embodiment, the automated fluid handling sys- 
30 tem adjusts pH, temperature, humidity, osmolarity, gas 
exchange, pressure (normal, hyper or reduced), nutrients lev-
els, cell inoculation ports, sample ports, and selective harvest-
ing of cells, and waste management. 
In another embodiment, cells canbe selectively removed or 
35 harvested from the cell culture chamber. In another embodi-
ment, cells include, but are not limited to, suspension, anchor-
age dependent, and stem cells either prokaryotic or eukary-
otic in type and mixtures or combinations thereof, where 
mixtures mean a culture of mixed cells and combination 
40 means isolated domains of each cell type. 
In another embodiment, cells are grown continuously in 
the laminar flow cell culture chamber. In accordance to 
another embodiment, the miniature laminar flow bioreactor 
can generate gradients of various growth factors to aid in the 
45 study of chemotaxis, or the migration of cells due to the 
presence of a chemical gradient. In accordance to yet another 
embodiment, the miniature laminar flow bioreactor can gen-
erate gradients of shear stress to aid in the study of mechano-
taxis, or the migration of cells due to the presence of a known 
50 shear stress. In accordance to yet another embodiment, the 
miniature laminar flow bioreactor can generate gradients of 
various drugs to aid in the study of cell apoptosis. 
In another embodiment, the bioreactor can be integrated 
directly to a micro-analytical system for further analysis of 
55 cells or of the product of cells activities generated in the 
bioreactor, such micor-analytical system generally take 
advantage of microfluidics to handle cells and cells products. 
Component List 
One embodiment of a bioreactor of this invention includes: 
60 	 conditioned gas chamber, 
fluid handling system including: 
peristaltic pump, 
logic inlet and outlet valves, and 
fluid reservoirs, 
65 	 thermal controller, 
Peltier-TEC device and fan, and 
CO2 -Gas Cylinder and regulator. 
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In other embodiment, the condition gas chamber is 
replaced by a gas infusion system for generated gasified 
medium. 
The present invention solves some problems inherent in the 
prior art by providing a device with selective cell removing 
capabilities that can culture different cell types long term. The 
bioreactor is a thin, pressure-driven culture chamber with two 
(or more) inlets and two (or more) outlets. The cover of the 
reactor consists of a porous respiratory active material to 
ensure adequate mass transport of O z and COz, while the 
underside consists of a thin microscope cover sheet to allow 
microscopic imaging or a second porous membrane. The 
working volume of the bioreactor is approximately 1 mL. 
An advanced fluid handling system has been developed to 
control fresh media infusion and allow for selective cell 
removal. The fluid handling system consists of two `logic' 
valves, a small peristaltic pump (InstechTM OEM P625), and 
three fluid reservoirs (media, PBS, and Trypsin). The first 
`logic' valve allows either the selection of fresh media or PBS 
to the inlets, or the selective removal of a section of the 
bioreactor by infusing a proteolytic enzyme (Trypsin) 
through one inlet and media through the other inlet(s). The 
lines exiting the bioreactor are draped along the roller bear-
ings of the peristaltic pump and connected to a second `logic' 
valve which directs all lines to the waste, or allows for the 
selection of a specific line to a sample reservoir. Flow pas-
sages in the `logic' valve ensure that only the desired reagent 
is permitted to enter into the desired line. Since the flow rates 
required to sustain a micro culture are small, the flow in the 
central channel will possess classical Hele-Slaw flow charac-
teristics. The flow is essentially a two-dimensional laminar 
flow created by the thin channel and the low velocity require-
ment. Laminar flow is characterized by fluid traveling in 
layers where each element travels smoothly along a simple, 
well-defined path. This fluid dynamic characteristic will be 
exploited in anchorage dependent cultures to harvest cells 
from specific regions of the chamber for analysis without 
disturbing others. Valving directs harvested cells to a sample 
reservoir or to waste. In the case of suspension cells, cells are 
harvested upon the infusion of new media. Incorporated into 
the miniature culture system is a temperature control system 
and gas control loop. The inclusion of these two systems will 
enable the miniature culture system to be autonomous. 
Bench Top Application 
The miniature culture system can be used autonomously as 
a bench top bioreactor system. The selective removal and 
viewing capabilities of the new cell culture system make it an 
ideal tool to perform and monitor cell migration assays. A 
precise, reproducible section of cells can be removed from the 
cell culture device by introducing an enzymatic protein to a 
strip of cells. Cells exposed to the enzymatic protein will 
dissociate from the growth substrate and be removed from the 
culture device upon infusion of new media. The design of the 
bioreactor housing and control system enable the system to sit 
directly on top of a microscope stage. This is ideal for phase 
or fluorescence time-lapse microscopy. Both environmental 
(i.e. chemical) and mechanical (i.e. shear) parameters could 
be examined in the bioreactor, and thus aid in determining 
factors that might have a significant impact on directed cell 
migration and/or wound healing. 
Integration with Micro-Analytical Device for In Situ 
Monitoring 
The miniature culture system is a novel device that may 
advance the development of micro analytical tools such as 
biological sentinels, biosensors, and lab-on-a-chip devices. 
Integrating the autonomous miniature culture system with a 
10 
micro-analytical device provides one with a powerful bio-
logical tool since cells can be cultured long term and released 
directly into an analytical tool without the need for human 
interaction. The analytical device can be tailored to perform a 
5 vast array of assays from monitoring changes in intracellular 
proteins or DNA structure to detecting chemical signals in 
response to exposed stressors over time. The integration of 
these two systems will enable the development of a com-
pletely autonomous miniature cell culture and analytical sys- 
io tem. Due to the size and volume requirements, the device will 
significantly reduce the reagent requirements for cell culture. 
The autonomous system can be tailored for either laboratory 
benchtop applications or for studies in remote and/or difficult 
environments (e.g. extra-terrestrial or low gravity studies). 
15 Flow visualization studies were performed using the above 
embodiment. The capabilities bioreactor and fluid handling 
system were tested. Food coloring was used to mimic differ-
ent cell culture reagents during different cell culture pro-
cesses. Flow visualization demonstrated the effectiveness of 
20 the miniature bioreactor to perform cell media infusion, PBS 
flush, dye/stain infusion, cell inoculation procedures, and 
enzymatic dissociation. The flow demonstrated its Hele-shaw 
characteristics and the reagents did not mix. The area chosen 
for selective removal was correctly distributed into the 
25 sample port while the other two regions were correctly circu-
lated into the waste bottle. 
Numerical studies were completed to examine different 
geometries before fabricating and experimenting with the 
miniature device. 
30 	 A prototype bioreactor was fabricated after studying the 
results of flow visualization studies. 
Initial studies demonstrated that BHK-21 cells could be 
cultured either on the membrane or on the glass top for several 
weeks at a time. 
35 	 A second prototype bioreactor was also fabricated, and the 
bioreactor was tested for bench top readiness so that it could 
be used as a plug and play cell culturing apparatus in micro-
fluidics cell analyzer system. 
Numerical shear level and chemotaxis (scalar transport) 
40 studies were performed in FluentTM 
The invention includes a miniature bioreactor vessel and 
fluid handling system to complement current micro analytical 
systems or other diagnostic tools for long term cell studies. 
The miniature bioreactor system is comprised of a biore- 
45 actor, fluid handling system, and a temperature controlled 
conditioned air chamber. The miniature bioreactor system 
cultures both suspension and anchorage dependent cells (ei-
ther procaryotic or eukaryotic in type), in normal, micro, or 
hypo gravity, and can be directly integrated with a micro 
5o analytical device for in situ analysis of cells and soluble 
factors. The fluid handling system not only provides the cul-
ture region with nutrients and waste removal, but enables 
cells to be selectively removed over time for real time long 
term cell culture studies. 
55 	 Due to the size of the bioreactor, it would make an `ideal' 
complete bench top cell culturing tool minimizing the need 
for expensive equipment and reagents. The culture device can 
be computer controlled reducing the time and effort of the 
investigator and uncertainty in the results. The device can 
60 culture both anchorage dependent and suspension cells, 
either prokaryotic or eukaryotice in type. Hence, the appara-
tus may be utilized for many different cellular research and 
commercial applications. 
The miniature culture system is a novel device that may 
65 advance the development of micro analytical tools such as 
biological sentinels, biosensors, and lab-on-a-chip devices. 
Integrating the autonomous miniature culture system with a 
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micro-analytical device provides one with a powerful bio- 	 operate as a plug and play unit, meaning that the bioreactors 
logical tool since cells can be cultured long term and released 	 of this invention can be directly integrated into a bench top 
directly into an analytical tool without the need for human 	 unit. The bioreactors represent an universal system for cul- 
interaction. The analytical device can be tailored to perform a 	 turing all cell types with minimal use of expensive reagents. 
vast array of assays from monitoring changes in intracellular 5 The chamber are microscope-ready ideal for morphological 
proteins or DNA structure to detecting chemical signals in 	 studies, cell migration/chemotaxis studies or to harvest cells 
response to exposed stressors over time 	 to prevent over-confluence. The bioreactors of this invention 
Finally, the miniature system could be exploited to perform 	 can be efficiently integrated with microfluidics device per- 
popular migration assays. The fluid handling system enables 	 mitting construction of autonomous bioreactor systems, per- 
the presence of a chemical gradient to study the response of io miffing monitoring with or without control feedback with the 
cells to different growth/healing chemicals. Both environ- 	 capability to remove sections of cells for in situ analysis using 
mental and mechanical parameters could be examined in the 	 remote sensing. 
bioreactor and thus aid in determining factors that might have 	 Suitable Reagents 
a significant impact on wound healing. 	 Suitable medium for use in this invention include, without 
A prototype miniature bioreactor system has been 15 limitation and depend on the cells being cultured, any cultures 
designed and fabricated to possess selective cell removing 	 medium now used or to be developed to support short, mod- 
capabilities. Initial studies demonstrate selective cell removal 	 erate, or long term cells cultures. One of ordinary skill in the 
capabilities and outline protocols for the use of the mini- 	 art will recognized that there are many cells and cell lines 
culture system. The new system was used to investigate fibro- 	 each having their own tailored growth medium and new grow 
blast cell migration under normal culture conditions. A strip 20 media are being developed daily. The bioreactors of this 
of cells are removed by implementing selective cell removal 
	
invention can be operated using any growth medium required 
protocols in the mini-bioreactor. Images of cell migration into 	 for the type of cell being cultured. 
the harvested region are captured with a Nikon TMS time- 	 Suitable cells of culturing with the bioreactors of this 
lapse phase contrast microscope and digitized to determine 	 invention include, without limitations, prokaryotic cells, 
migration times. Additionally, the system can be used to study 25 eukaryotic cells (plant, animal or fungi), stem cells (any 
cell culture response to a gradient of a known chemo-attrac- 	 organism that produces stem cells), mixtures or combinations 
tant. Thus, the system can be used to study the ability to 	 thereof. Although the bioreactors are set up for cell growth 
culture contact-inhibited, anchorage-dependent cells for an 	 and proliferation, the bioreactors can also be used to studies 
extended period of time, determine the limits and repeatabil- 	 viruses and viral infections, by growing a stable cell popula- 
ity of the device, and demonstrate the ability to exploit the 30 tion and then infecting it with a virus and monitor the effects. 
miniature culture system for ground based migration/chemo- 	 Introduction 
taxis assays. 	 Micro-fluidics is a developing field that possesses great 
From Presentation 	 promise for enhancing cell biology analysis and remote 
Technical Information 	 monitoring/sensing capabilities, especially for applications 
The working volume of the chamber used in the experi-  35 being developed by and for NASA. In addition to a significant 
mental section as 1 mL. The bioreactors are pressure driven 	 decrease in payload requirements of micro-fluidic devices, 
and are based on a Hele Shaw type system, supporting lami- 	 the devices are particularly well-suited for the challenges and 
nar flow evidenced by extremely low shear under normal 
	
limitations presented in biochemical analyses required for 
working conditions. The bioreactor can be equipped with a 	 remote monitoring. Since mammalian cells respond chemi- 
controlled gas chamber separated from the growth zone via a 40 cally and physically to their environment, animal cells are 
gas permeable membrane. The conditioned gas is supplied 
	
being considered for use as biological sentinels (early warn- 
from a 5% CO2 pressurized tank, where the amount of gas 	 ing of hazardous environmental factors for humans in space) 
supplied is verified using a Fryrite Gas Analyzer. Gas 	 and remote monitoring tools. To support this effort, a novel 
exchange (CO2 and 02) is achieved via a gas permeable 	 miniature culture system (<1 mL) has been designed for the 
membrane between the bioreactor growth zone and the con-  45 long-term culture of both anchorage dependent and suspen-
ditioned gas chamber. Temperature is maintained externally 	 sion cells. 
with a Peltier element and a PID controller. A fluid handling 	 Animal cells have strict demands on their growth condi- 
system controls the fluids entering and leaving the zones of 	 tions including pH, temperature, oxygen, and nutrient supply. 
the bioreactor via inlet and outlet valves. The fluids are sup- 	 These demands must be met in the design of a culture system, 
plied from reservoirs via the valve, where the valves are used 50 especially a miniature culture system, while maintaining a 
to select make up of the fluid being supplied. In many embodi- 	 low shear environment. In addition, the system should have 
ments, the zones are supplies with a medium that include a 	 the capability to harvest a cell population is required to pre- 
medium carrier having appropriate nutrients from a medium 	 vent the cells from losing their ability to divide and prolifer- 
reservoir to this can be added proteases for harvesting from a 	 ate. The system should also have the capability to selectively 
protease reservoir or an agent to induce a specific effect. 	 55 sample cells over time to enable monitoring of alterations in 
In certain embodiments, the bioreactor represents a minia- 	 cell gene expression or production during long term missions 
ture system and is mobile and has minimal reagent use for 	 or in extraterrestrial environments or to monitor cells sub- 
automated and unmanned operation in remote location such 
	 jected to a stress factor or exposed to other cells types. 
as space, mines (bio-sensors), nuclear power plants (bio- 	 Miniature Bioreactor and Flow Circuit Development 
sensors), chemical plants (bio-sensors), etc. The bioreactors 60 	 A miniature flat plate bioreactor chamber was designed for 
of this invention can be used for AD or Suspension Cells, for 	 short, moderate, and long term cultures of both anchorage 
short, moderate or long term cell cultures. The bioreactors of 
	
dependent and suspension cells, either prokaryotic or eukary- 
this invention is ideal for the following types of studies: cell 	 otic in type. The miniature chamber can be constructed with 
migration studies; chemotaxis studies, and co-culture inter- 	 a volume of <1 mL, but the chamber can be of any desired 
face studies. 	 65 volume. 
The bioreactors of this invention is also ideally well suited 
	
The inventors constructed an embodiment of a chamber 
for bench top miniature long term culture unit, which can 	 from a delrin block about 0.635 mm (0.25 in). The block was 
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milled with a square or rectangular through-hole about 2 	 zone inlets 106a&b. The dashed line separating the zones 
cmx2 cm. Of course, an ordinary artisan should recognize 	 104a and 104b is only to aid in visualization and does not 
that the bio-reactor can be constructed out of any suitable 	 represent a physical barrier of any kind, because the zones are 
material and can be constructed to be of any desired size and 
	
laminar flow isolated. 
shape. Square recesses were fabricated in the top and bottom. 5 	 Upstream of the pump 110 is an inlet valve 118 having 
At least one of the recesses is adapted to receive a transparent 	 three inlet valve inlets 120a-c and two inlet valve outlets 
member. In certain embodiments, especially embodiments 	 122a&b. As well be shown and discussed herein, the inlet 
where needed gases are transmitted with the medium (dis- 	 valve 118 can include additional inlets. The inlet valve outlets 
solved in the medium), the chamber includes two transparent 	 122a&b are connected by flow conduits 124a&b to their 
members, one situated in the top recess and the other in the io respective pump inlet ports 112a&b. Upstream of the inlet 
bottom recess. In certain embodiments, a thickness or a 	 valve 118 are three reservoirs 126a-c, each having an outlet 
height of the chamber, the gap between the top member and 
	
128a-c. The reservoir outlets 128a-c are connected by flow 
the bottom member, is about 2 mm. However, larger and 	 conduits 130a-c to their respective inlet valve inlets 120a-c. 
smaller thicknesses can be used. Thus, the thickness can 	 Downstream of the chamber 102 is an outlet valve 132 
range from about >one cell thickness to ten of millimeters. In 15 having two inlets 134a&b and three outlets 136a-c, one outlet 
certain embodiments, the thickness ranges from about a cell 
	
136c is optional and is used when medium recirculation is 
thickness to about 10 mm. In other embodiments, the thick- 	 desired. The zone outlets 108a&b are connected by flow 
ness ranges between about 0.1 mm and 5 mm. In other 	 conduits 138a&b to their respective outlet valve inlets 
embodiment, the thickness ranges between 0.5 mm and about 	 134a&b. Downstream of the outlet valve 132 is a sample 
4 mm. In other embodiments, the thickness ranges between 20 collection container 140 having a sample inlet 142 and a 
about 1 mm and about 3 mm. The transparent member is then 	 waste container 144 having a waste inlet 146. The outlet valve 
sealed in place to form one interior surface of the chamber. 	 outlet 136a is connected by a flow conduit 148 to the sample 
Optionally, the chamber can include one transparent member 	 inlet 142. The outlet valve outlet 136b is also connected by a 
and one transparent, gas permeable membrane, where the 	 flow conduit 150 to the waste inlet 146. The optional outlet 
membrane can be disposed in the top recess or the bottom 25 valve outlet 136c is connected by an optional flow conduit 
recess. A suitable gas permeable membrane such as a gas 	 152 to a recycle inlet valve inlet 120d, where the amount of 
permeable, polystyrene matrix membrane can be used, but 	 fresh and recycled medium is controlled by the valve 118. 
any transparent, gas permeable membrane can be used as 	 However, flow regulators or controllers can also be used to 
well. The transparent member can be glass cover-slips, but 	 improve flow control. 
any transparent member can be used as well. The transparent 30 	 Referring now to FIG. 113, a block diagram of another 
members or the transparent member and the membrane are 	 embodiment of a laminar flow bioreactor apparatus of this 
secured using a biocompatible silicone adhesive such as Dow 	 invention, generally 100, is shown to include two laminar 
Corning, RTV 111, but any biocompatible adhesive can be 	 flow, cell culture chambers 102a&b having first laminar flow 
used as well. 	 cell proliferation zone 104a&a' and a second laminar flow 
In certain embodiments, the transparent membrane is 35 cell proliferation zone 104b&b'. Upstream of the chambers 
transparent of a desired frequency range of electromagnetic 	 102a&b are two peristaltic pumps 110a&b. 
radiation (light). In most embodiments, the frequency range 	 Upstream of the pumps 110a&b are inlet valves 118a&b. 
is visible light, but in other embodiments, the frequency range 	 Upstream of the inlet valves 118a&b are reservoirs 126a-c 
could be IR, near IR, and UV. Of course, the bioreactors of 	 and 126a'-c'. Downstream of the chambers 102a&b are outlet 
this invention can also be equipped with filters that narrow the 40 valves 132a&b. Downstream of the outlet valves 132a&b are 
range of light being viewed or transmitted through the zones 	 sample collection container 140a&b and a waste container 
of the chamber. Additionally, each zoned can have a different 	 144. Again, if medium recycling is contemplated, then the 
filter and a different range of transparency. 	 apparatus 100 also include recycle conduits 152a&b. 
The inventors then milled two cylindrical inlets and two 	 The components are interconnected by conduits connect- 
cylindrical outlets form opposite side of the box into the 45 ing outlets of one component to inlets of an downstream 
chamber. The inlets and outlets are adapted to receive tubes 	 components and connecting inlets of one component to out- 
for attaching supply and release conduits thereto. The inven- 	 lets of an upstream component. Due to space constraints, the 
tors used 0.112 mm (OD) diameter stainless tubes, but any 	 conduits, inlets and outlets are not labeled, but are clearly 
tube can be used; provided, of course, that tubes are biocom- 	 understood by the conduit starts and stops. 
patible. In certain embodiments, the inlets include small dif-  50 	 In the two embodiments, the arrows associated with the 
fusers formed in the chamber at chamber ends of the inlets to 	 conduits evidence the direction of fluid flow into and out of 
lower inlet fluid velocities, to spread a fluid flow profile and to 	 each component. 
prevent the formation of fluid jets near the inlet. In other 	 The two bioreactor apparatus embodiments 100 of this 
embodiments, the inlets include the diffusers, while the out- 	 FIGS. 1A&B can be of any size. In certain embodiments, the 
lets includes collectors to lower outlet fluid velocities, to 55 bioreactor apparatus 100 is a miniature laminar flow bioreac- 
spread a fluid flow profile and to prevent the formation of fluid 	 tor, where the chamber 102 has a volume of about 1 mL or 
jets near the outlet. 	 less. Thebio-reactor apparatus 100 can comprise a closed and 
Referring now to FIG. 1A, a block diagram of an embodi- 	 aseptic environment adapted to grow cells that include, but 
ment of a laminar flow bioreactor apparatus of this invention, 	 are not limited to, prokaryotic or eukaryotic suspension cells, 
generally 100, is shown to include a laminar flow, cell culture 60 prokaryotic or eukaryotic anchorage dependent cells, and/or 
chamber 102 having a first laminar flow cell proliferation 	 stem cells under laminar flow conditions. The and/or is 
zone 104a and a second laminar flow cell proliferation zone 	 includes to address cultures comprising a mixture of cells, 
104b. The two zones 104a and 104b include zone inlets 	 such as stem cell introduction into a stable cell culture to 
106a&b, and zone outlets 108a&b. Upstream of the chamber 	 study stem cell integration or stem cell effects, and to address 
102 is a peristaltic pump 110 having two inlet ports 112a&b 65 cultures comprising a combinations of cells such as multi- 
and two outlet ports 114a&b. The pump outlet ports 114a&b 
	
layer cell cultures, where each layer comprises a different cell 
are connected by flow conduits 116a&b to their respective 	 line or type, or isolated islands of cells. The laminar flow 
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bioreactor 100 can be fully automated so it can run autono- 	 ratus 270 also includes a top transparent member (not shown) 
mous, allowing its use and operation in remote locations or in 	 and a bottom transparent member (not shown) defining a 
harsh and dangerous environments including space environ- 	 volume 284. The volume 284 includes four laminar flow 
ments. 	 zones 286. Each zone 286 includes an inlet 288 having a 
Referring now to FIGS. 2A&B, an embodiment of a cham-  5 diffuser 290, where the diffuser 290 is adapted to spread a 
ber of this invention, generally 200, is shown to include a 	 flow of fluid as it enters its corresponding zone 286. Each 
body 202. The body 202 includes a rectangular or square 	 zone 286 also includes an outlet 292 having a collector 294, 
aperture 204 therethrough. The apparatus 200 also includes a 	 where the collector 294 is adapted to reduce flow constric- 
top recessed area 206 and a bottom recessed area 208. The 	 tions of fluid as it exits its corresponding zone 286. The inlets 
apparatus 200 also includes a top transparent member 210 i o 288 are fitted with inlet tubes 296 and the outlets 292 are fitted 
and a bottom transparent member 212 defining a volume 214. 	 with outlet tubes 298. The tubes 296 and 298 are adapted to be 
The volume 214 includes two laminar flow zones 216. Each 	 receive tubing used as conduits to connect the inlets and 
zone 216 includes an inlet 218 having a diffuser 220, where 	 outlets to inlet and outlet valves, respectively as described 
the diffuser 220 is adapted to spread a flow of fluid as it enters 	 herein. The dividing dashed line through the volume 284 is 
its corresponding zone 216. Each zone 216 also includes an 15 included to show the laminar flow separation of the zones 
outlet 222 having a collector 224, where the collector 224 is 	 286, it is not a physical barrier, but simply to aid in the 
adapted to reduce flow constrictions of fluid as it exits its 	 visualization of the zones 286, because the zones are laminar 
corresponding zone 216. The inlets 218 are fitted with inlet 	 flow isolated. 
tubes 226 and the outlets 222 are fitted with outlet tubes 228. 	 Referring now to FIGS. 3A&B, an embodiment of a gas 
The tubes 226 and 228 are adapted to be receive tubing used 20 supply and control chamber apparatus of this invention, gen- 
as conduits to connect the inlets and outlets to inlet and outlet 	 erally 300, is shown to include a body 302. The body 302 
valves, respectively as described herein. Although in FIG. 213, 	 includes a rectangular or square aperture 304 therethrough 
the diffusers 220 are shown to extend the entire height of the 	 adapted to correspond to the aperture 204 of the chamber 200 
volume 214, the diffusers 220 can have a height less than the 	 of FIG. 2A. The apparatus 300 also includes a raised bottom 
entire height of the volume 214. The same is also true of the 25 portion 306 adapted to be inserted into the top or bottom 
collectors 224. The height of the diffusers 220 and collectors 	 recessed area 206 or 208 of the chamber 200 of FIG. 2A, 
224 must be sufficient to spread the fluid flow into or out of the 	 depending on which member 210 or 212 is a gas permeable 
zones 216 to prevent jetting or channeling and to maintain 	 membrane. The raised bottom portion 306 is shown here 
laminar flow conditions during cell seeding and proliferation. 	 slightly tapered in a convex taper, but can be substantially 
Of course, for harvesting, fluid conditions can be increased as 30 straight. The apparatus 300 also includes a top transparent 
needed to affect a given harvesting rate. The dividing dashed 	 member 308 so that the chamber can be observed through the 
line through the volume 214 is included to show the laminar 	 gas chamber apparatus and forming a gas cavity 310, which 
flow separation of the zones 216, it is not a physical barrier, 	 when the gas chamber apparatus 300 is properly situated in a 
but simply to aid in the visualization of the zones 216, because 	 recessed area of the chamber 200 is defined by the aperture 
the zones are laminar flow isolated. 	 35 304, the member 210 or 212 and the member 308. The appa- 
Referring now to FIGS. 2C&D, a perspective 3D rendering 	 ratus 300 also includes a gas inlet 312 having a gas inlet tube 
of the apparatus 200 is shown with appropriate features 	 314 fitted therein. The apparatus 300 also includes a gas outlet 
labeled as described above. FIG. 2D shows the relative size of 
	
316 having a gas outlet tube 318 fitted therein. The gas inlet 
the chamber 200 compared to a quarter. 	 312 is adapted to allow a gas composition to be introduced 
Referring now to FIG. 2E, an embodiment of a chamber of 40 into the gas cavity 310, while the gas outlet 316 is adapted to 
this invention, generally 240, is shown to include a body 242. 	 allow the gas composition to exit the gas cavity 310. The gas 
The body 242 includes a rectangular or square aperture 244 
	
in the gas cavity 310 in conjunction with the gas permeable 
therethrough. The apparatus 240 also includes a top recessed 	 membrane to allow gas transport into and exchange with the 
area 246 and a bottom recessed area (not shown). The appa- 	 zones 216. Of course, a similar design can be used for the 
ratus 240 also includes a top transparent member (not shown) 45 chambers 240 and 270 of FIGS. 2E&F, respectively. Addi- 
and a bottom transparent member (not shown) defining a 	 tionally, the gas cavity 310 can be physically partitioned so 
volume 254. The volume 254 includes three laminar flow 	 that a different gas composition can be supplied to each zone, 
zones 256. Each zone 256 includes an inlet 258 having a 	 such a partitioning would, of course, require additional gas 
diffuser 260, where the diffuser 260 is adapted to spread a 	 inlets and outlets as shown in FIG. 3C. 
flow of fluid as it enters its corresponding zone 256. Each 50 	 Referring now to FIGS. 4A&B, a plan view and 3D per- 
zone 256 also includes an outlet 262 having a collector 264, 	 spective view of a combined apparatus of this invention, 
where the collector 264 is adapted to reduce flow constric- 	 generally 400, is shown to include the chamber 200 and the 
tions of fluid as it exits its corresponding zone 256. The inlets 	 gas chamber 300 properly attached. The chamber 200 is 
258 are fitted with inlet tubes 266 and the outlets 262 are fitted 	 shown in black line and the gas chamber 300 is shown in grey 
with outlet tubes 268. The tubes 266 and 268 are adapted to be 55 line. 
receive tubing used as conduits to connect the inlets and 
	
Referring now to FIGS. 5A-C, an embodiment of an inlet 
outlets to inlet and outlet valves, respectively as described 	 valve apparatus of this invention, generally 500, is shown to 
herein. The dividing dashed line through the volume 254 is 	 include a body 502. The body 502 includes two valves 504. 
included to show the laminar flow separation of the zones 	 Each valve 504 includes a cylindrical cavity 506 adapted to 
256, it is not a physical barrier, but simply to aid in the 6o receive a rotatable valve barrel 508 having a handle 510. The 
visualization of the zones 256, because the zones are laminar 	 apparatus 500 also includes five inlets 512a-e, all of which 
flow isolated. 	 can be equipped with inlet tubes (not shown). The inlets 
Referring now to FIG. 2F, an embodiment of a chamber of 
	
512a-e are adapted to be connected with reservoirs or to 
this invention, generally 270, is shown to include a body 272. 	 support medium recycling. The apparatus 500 also includes 
The body 272 includes a rectangular or square aperture 274 65 two outlets 514a -b adapted to be connected to the inlets of the 
therethrough. The apparatus 270 also includes a top recessed 	 zone 216 of the chamber 200 of FIG. 2A. All of the inlets 
area 276 and a bottom recessed area (not shown). The appa- 	 512a-e and the outlets 514a -b open into their respective cylin- 
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drical cavities 506. The barrels 508 include flow paths per- 	 be directed via a waste collection conduit 748 to a waste 
mitting different inlets to be connected to the outlets to con- 	 container orbag (not shown). Alternatively, the spent medium 
trol the medium composition being supplied to each zone. 	 can be direct via a sampling/recycling conduit 750 to either a 
Thus, each valve 504 can be used to combine up to three flow 	 sample collection container or to the re-circulation conduit 
together to form the outlet flow. Looking at FIG. 5D, a per-  5 730. The gas chamber 712 include a gas inlet 752 and a gas 
spective 3D rendering of the valve 500 is shown. The arrows 	 outlet 754. The gas inlet 752 is connected via a gas inlet 
indicate the flow directions associated with the inlets 512a-e 	 conduit 756 to a gas handling system (not shown) adapted to 
and outlet 514a-b. The 3D rendering shows an inlet on the 	 supply the gas chamber 712 with a gas composition to support 
right side of the right valve, which represent an error in the 	 gas transport and exchange with the zones 710a&b. The gas 
rendering. However, each valve 504 can include additional io outlet 754 is connected via a gas outlet conduit 758 to a gas 
inlets and outlets, but the barrel configuration and construc- 	 disposal system or vent (not shown), depending on the nature 
tion becomes more challenging. 	 of the gas composition being supplied to the chamber 712. 
Referring now to FIGS. 6A-D, an embodiment of an outlet 	 Referring now to FIG. 8, another embodiment of a biore- 
apparatus of this invention, generally 600, is shown to include 	 actor of this invention, generally 800, is shown to include a 
a body 602. The body 602 includes a valve 604. The valve 604 15 housing 802 having four corner apertures 804 adapted to 
includes a cylindrical cavity 606 adapted to receive a rotatable 	 receive a cover. The housing 702 includes a bottom mounting 
valve barrel 608 having a handle 610. The apparatus 600 also 	 member 806 upon which other components are mounted and 
includes two inlets 612, all of which can be equipped with 
	
below which certain tubing leading to certain components 
inlet tubes (not shown). The inlets 612 are adapted to be 	 run. Mounted on the member 806 is a laminar flow chamber 
connected with the chamber outlet tubes 228. The apparatus 20 808 of FIG. 2A having two laminar flow zones 810a&b. The 
600 also includes two outlets 614 adapted to be connected to 	 inlets and outlets of the chamber 808 (not shown) are con- 
the a sample collection container or to a waste bag as shown 	 nected to tubes running under the mounting member 806. The 
in FIG. 1A. All of the inlets 612 and the outlets 614 open into 	 inlet tubes terminate in two tube inlets 814a&b, and the outlet 
the cylindrical cavity 606. The barrel 608 includes flow paths 	 tubes terminate in two tube outlets 816a&b. The apparatus 
permitting the inlets to be connected to wither one of the 25 800 also includes a pump 818, an inlet valve 820, and an outlet 
outlets to control the chamber effluent to either the sample 	 valve 822 all mounted on the mounting member 806. The 
collection container or the waste bag. Of course, the outlet 	 apparatus 800 also include conduits connecting the compo- 
value 600 can include additional outlets for directly spent 	 nents. In this configuration, the inlet valve 820 includes five 
medium to the inlet valve 500 for re-circulation to the cham- 	 inlets 824a-e. The inlet 824a is connected to a first reservoir 
ber 200. 	 3o not shown via a conduit 826a; the inlet 824b is connected to 
Referring now to FIG. 7, an embodiment a bioreactor of 	 a second reservoir not shown via a conduit 826b, the inlet 
this invention, generally 700, is shown to include a housing 	 824c is connected to a second reservoir not shown via a 
702 having four corner apertures 704 adapted to receive a 	 conduit 826c, and the inlets 824d&e are connected via T 
cover (not shown). The housing 702 includes a bottom 	 conduits 826d&e from a T connector 828, which is connected 
mounting member 706 upon which other components are 35 to a medium re-circulation conduit 830. The inlet valve 820 
mounted and below which certain tubing leading to certain 	 also includes two outlets 832a&b connected to via pump inlet 
components run. Mounted on the member 706 is a laminar 	 conduits 834a&b to pump inlets 836a&b of the pump 818. 
flow chamber 708 of FIG. 2A having two laminar flow zones 	 The pump 818 also includes pump outlets 838a&b which are 
710a&b The chamber 708 are equipped with a gas chamber 	 connected via pump outlet conduits 840a&b. The tube outlets 
712. The inlets and outlets of the chamber 708 (not shown) are 4o 816a&b for removing spent medium from the zones 810a&b 
connected to tubes running under the mounting member 706. 	 are connected via outlet valve inlet conduits 842a&b to inlets 
The inlet tubes terminate in two tube inlets 714a&b, and the 	 844a&b of the outlet valve 822. The outlet valve 822 has two 
outlet tubes terminate in two tube outlets 716a&b. The appa- 	 outlets 846a&b. Inthis configuration, the outlet valve 822 has 
ratus 700 also includes a pump 718, an inlet valve 720, and an 	 two settings for directing spent medium. The spent medium 
outlet valve 722 all mounted on the mounting member 706. 45 can be directed via a waste collection conduit 848 to a waste 
The apparatus 700 also include conduits connecting the com- 	 container orbag (not shown). Alternatively, the spent medium 
ponents. In this configuration, the inlet valve 720 includes 	 can be direct via a sampling/recycling conduit 850 to either a 
five inlets 724a-e. The inlet 724a is connected to a first res- 	 sample collection container or to the re-circulation conduit 
ervoir not shown via a conduit 726a; the inlet 724b is con- 	 830. 
nected to a second reservoir not shown via a conduit 726b, the 50 	 In this configuration, the bioreactor 800 does not include a 
inlet 724c is connected to a second reservoir not shown via a 	 gas chamber, but instead includes a gas infusion system 852. 
conduit 726c, and the inlets 724d&e are connected via T 
	
The gas infusion system 852 is adapted to introduce gas into 
conduits 726d&e from a T connector 728, which is connected 	 the medium downstream of the pump 818 and upstream of the 
to a medium re-circulation conduit 730. The inlet valve 720 	 tube inlets 814a&b. The system 852 includes two bubble 
also includes two outlets 732a&b connected to via pump inlet 55 traps 854a&b connected via pump outlet conduits 840a&b to 
conduits 734a&b to pump inlets 736a&b of the pump 718. 	 bubble traps medium inlets 856a&b. The bubble traps 
The inlet valve 720 includes valve selection handles 721a&b, 	 854a&b are connected via gas supply conduits 858a&b to a 
which control the fluid in and out of the valve 720. The pump 	 gas supply (not shown), where each gas supply conduit 
718 also includes pump outlets 738a&b which are connected 
	
858a&b generally includes gas regulator valve (not shown) to 
via pump outlet conduits 740a&b to the tube inlets 714a&b 60 control the rate of gas supplied to the traps 854a&b. The 
for supplying medium to the zones 710a&b. The tube outlets 	 bubble traps 854a&b are adapted to supersaturate the 
716a&b for removing spent medium from the zones 710a&b 	 medium with a gas composition. The gasified medium then 
are connected via outlet valve inlet conduits 742a&b to outlet 	 exits the bubble traps 854a&b through bubble trap outlets 
valve inlets 744a&b of the outlet valve 722. The outlet valve 	 860a&b, which are connected via bubble trap outlet conduits 
722 has two outlets 746a&b. In this configuration, the outlet 65 862a&b to gasified medium inlets 864a&b of two gas 
valve 722 has two settings for directing spent medium con- 	 exchangers 866a&b. The gas exchangers 868a&b include gas 
trolled by an outlet valve handle 723. The spent medium can 	 exchanged medium outlets 868a&b, which are connected via 
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gas exchanged medium conduits 870a&b to the tube inlets 	 method can optionally include a label cells step 910, where a 
814a&b of the zones 810a&b. The gas exchangers 866a&b 	 cell label is introduced into the medium to label the cells prior 
also include gas outlets 872a&b connected via gas outlet 	 to harvesting the cell population in a harvest cells step 912. 
conduits 874a&b to gas vents (not shown). The gas exchang- 	 Alternatively, once the desired cell population is achieved, the 
ers 866a&b provide for gas exchange in the medium so that 5 cell population can be harvested directly in the harvest cells 
the medium includes a desired concentration of the gas com- 	 step 912. During cell proliferation, spent medium is for- 
position introduced into the medium by the bubble trap 	 warded to a waste container in an accumulate waste step 914. 
854a&b. The system 852 is adapted to supply the zones 	 After cell harvesting, medium is separated from the harvested 
810a&b with a medium including an amount of a dissolved 	 cells and forwarded to the waste container. The harvested 
gas composition to achieve a desired affect. The gas compo-  io cells are then collected in a collect harvested cells step 916. 
sition can be designed to support cell growth or subject the 	 After collecting the harvested cells, the cells can be stored 
cells in the zones to adverse conditions to monitor cell 	 stopping the study in a stop step 918. Alternatively, the col- 
response. The gas composition can be changed and agents 	 lected cells can be forwarded to a cell analysis system in an 
introduced into the medium to test drugs or other gas com- 	 analyze collected cells step 920. The method 900 can also 
positions to test and monitor cell response and recovery. 	 15 optionally include the step of recycling spent medium in a 
Methods Using the Bioreactors of this Invention 	 recycle medium step 922. The method 900 can also include 
Generally, the methods of the present invention for short, 	 processing waste or spent medium to extract cell products, if 
moderate or long term cell cultures using the apparatuses 700 	 the cells are secretory cells in a process waste step 924. 
or 800 described above, include the step of isolating cells 	 Referring now to FIG. 913, an embodiment of a method of 
(either prokaryotic or eukaryotic). After isolation, the cells 20 this invention, generally 950, is shown to include a start step 
are then inoculated into zones of the laminar flow cell culture 	 952, which is merely to evidence a start in an culture study. 
chamber 200, 240 or 270 using a culture medium, where the 	 The start step 902 would generally include all the preparatory 
chamber can be sterilized. The cells are then allowed to pro- 	 work necessary to perform a cell cultures study using the 
liferate to desired cell density for suspension cell lines or to a 	 laminar flow cell culture chamber 200, 240 or 270 described 
confluent monolayer for adherent cell lines. If desired, cells 25 above. After everything is ready, the method includes the step 
are treated with a label or other tag such as a fluorescent cell 	 of isolating cells for culturing in an isolate cells step 954. The 
probe. Once a desired population is attained, the cells are 	 isolated cells are mixed with medium and introduced into one 
harvested by manipulating fluid dynamics to achieve cell 	 or all of the zones of a laminar flow chamber of this invention 
removal from one or all zones of the chamber. The harvesting 	 in an inoculate cells step 956. After inoculation, medium flow 
can include removing spent media, washing with saline, and 30 is adjusted to support a laminar flow of medium to support 
treating with protease to break protein anchorages. The 	 cell growth in the zones in a proliferate cells step 958. Once a 
method can also include the step of accumulating waste in a 	 desired population of cells has been reached in a zone, the 
waste bag. Harvested cells are collected. The collected cells 	 method can optionally include a label cells step 960, where a 
can then be sent to an analytical system for additional analy- 	 cell label is introduced into the medium to label the cells prior 
sis. For longer cell cultures, harvesting is allowed to continue 35 to harvesting the cell population in a harvest cells step 962. 
to a population so that the remaining cells in the harvested 
	
Alternatively, once the desired cell population is achieved, the 
zone can migrate into the harvested area, and re-grow in the 	 cell population can be harvested directly in the harvest cells 
harvested area. Harvesting can be repeated whenever the cell 	 step 962. During cell proliferation, spent medium is for- 
population reaches a desired population. In this way, cell 	 warded to a waste container in an accumulate waste step 964. 
cultures can be maintained for long periods of time for long 4o After cell harvesting, medium is separated from the harvested 
term cultures. 	 cells and forwarded to the waste container. The harvested 
For chemotaxis studies, the method can include the step of 	 cells are then collected in a collect harvested cells step 966. 
adding different chemical agents to the culture medium dur- 	 Alternatively, the collected cells can be forwarded to a cell 
ing cell migration and observing the migration with the aid of 	 analysis system in an analyze collected cells step 970. The 
a microscope to determine the effects of the chemical agent 45 method 950 can also optionally include the step of recycling 
on cell migration and proliferation. For apoptosis studies, the 	 spent medium in a recycle medium step as in the method 900 
method can include the step of adding known drugs to the 	 above (not shown). The method 950 can also include process- 
culture medium and observing cell death rate with the aid of 	 ing waste or spent medium to extract cell products, if the cells 
a microscope or external micro-analytical system. For 	 are secretory cells in a process waste step 974. The method 
mechanotaxis studies, the method can include the step of 50 950 is designed for moderate to long term cultures studies, 
adjusting a shear level or shear gradient using different flow 	 where a cell population is allowed to grow to a given density 
rates for different inlets and observing cell migration and/or 	 harvested to a relatively low population so that the remaining 
proliferation with the aid of a microscope. 	 cells can migrate and re-populated the harvested zone. This 
Referring now to FIG. 9A, an embodiment of a method of 	 process is repeated as long as the remaining cells are capable 
this invention, generally 900, is shown to include a start step 55 of re-populating the zone. Thus, the method 950 includes a 
902, which is merely to evidence a start in an culture study. 	 promote cell migration step 976 permitting moderate and 
The start step 902 would generally include all the preparatory 	 long term culture studies. 
work necessary to perform a cell cultures study using the 	 Bioreactor Characteristics and Properties 
laminar flow cell culture chamber 200, 240 or 270 described 
	
As stated in the priority document, the laminar flow cell 
above. After everything is ready, the method includes the step 60 culture apparatus of this invention includes a laminar flow cell 
of isolating cells for culturing in an isolate cells step 904. The 	 culture chamber as shown in FIGS. 2A-F. The chamber has 
isolated cells are mixed with medium and introduced into one 	 disposed on its top a controlled gas chamber as shown in FIG. 
or all of the zones of a laminar flow chamber of this invention 	 3A-413. Once assembled, the culture chamber is are separated 
in an inoculate cells step 906. After inoculation, medium flow 	 from the controlled gas chamber by a gas permeable mem- 
is adjusted to support a laminar flow of medium to support 65 bran. 
cell growth in the zones in a proliferate cells step 908. Once a 	 The laminar flow cell culture chamber is built to allow 
desired population of cells has been reached in a zone, the 	 laminar flow of fluids. Fluids (not shown) injected through 
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conduits connected to the culture chamber inlets provide flow 
in a parallel direction (no mixing) through the culture cham-
ber and exit via the culture chamber outlets through exit 
conduits subsequent handling and/or processing. The culture 
chamber does not required a physical barrier such as a mem-
brane to separate flows in the laminar flow zones within the 
chamber. The distance that separates the laminar flows is 
typically about 2 mm, but the separation can be more of less 
depending on design consideration and the degree zone inter-
action is desired. In another configuration as shown in FIGS. 
2E&F, the laminar flow cell culture chamber can handle more 
than two laminar flow regions. Such configurations allow 
co-culture of two or more than two batches of cells, simulta-
neously. The flow isolation also permits each region or zone 
to be include different medium so that signaling between flow 
regions are be studied. 
In miniature embodiment, the culture laminar flow cell 
culture chamber has a volume of one mL or less. In most 
embodiments, the laminar flow cell culture chamber includes 
a substrate conducive to cell growth forming an interior sur-
face of the chamber. Such substrates are typically made of a 
polystyrene matrix, but any cell conducive substrate can be 
used as well. 
In most embodiments, the laminar flow cell culture cham-
ber is sealable and sterilized to provide cells with optimum 
growth conditions. In most embodiments, the outer walls of 
the laminar flow cell culture chamber are made of optically 
transparent biocompatible materials such as glass orpolysty-
rene. Optically transparent walls provide a window for direct 
observation of cells through a detection apparatus such as a 
light microscope or other optical detection device. 
The laminar flow cell culture chamber is connected to the 
other components of the bioreactor via conduits or tubing that 
connects the inlets and outlets of the chamber to inlet and 
outlet control valves. The inlet and outlet valves are provided 
for transferring materials into and out of the zones of the 
laminar flow cell culture chamber. 
Details of the laminar flow cell culture chamber are illus-
trated in FIGS. 2A-D. In this configuration, the chamber has 
two ingoing connections and two outgoing connections. 
However, in the configurations of FIGS. 2E-F, the chamber 
has more than two connections in and out. In some embodi-
ments, especially for miniature embodiments, the chamber 
has inside dimensions of about 0.8 inch long by about 0.6 inch 
wide and about 0.06 inch thick. Dimensions used in these 
descriptions are meant by way of example and are not meant 
to limit the scope of the invention. 
Details of the controlled gas chamber are shown in FIGS. 
3A&B. The gas chamber is adapted to allow a controlled gas 
composition, flow and pressure into the gas chamber so that 
gas can be transferred into and exchanged with the zones via 
the gas permeable membrane, such as, but not limited to, a 
polystyrene gas permeable member. In some embodiments, 
especially for miniature embodiments, the gas chamber has 
dimensions of about 0.8 inch long, about 0.6 inch wide and 
about 0.22 inch thick. The controlled gas chamber has gas 
connections to a gas handling system to allow the passing of 
gas through the gas chamber. 
Details of an embodiment of an inlet valve for use in this 
invention is shown in FIGS. 5A-D, while details of an 
embodiment of an outlet valve for use in this invention is 
shown in FIGS. 6A-D. The valves can be under computer 
control for automatic control of the opening and closing of the 
valves, allowing automated and unmanned operation of the 
bioreactor. Although the inventors constructed valves espe-
cially for the bioreactors of this invention, it should be rec-
ognized that any valve or series of valves can be used to 
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facilitate the introduction and removal of medium into and 
out of the zones of the culture chamber. 
FIGS. 7&8 illustrate embodiments of a bioreactor of this 
invention including a cultures chamber, inlet valve, outlet 
5 valve and a fluid handling system mounted on a mounting 
member of a housing. FIGS. 1A&B illustrate flow diagrams 
depicting flow pathways for two illustrative embodiments of 
a bioreactor of this invention. In the flow diagram of FIG. 1A, 
three fluid reservoirs (e.g., medium, Trypsin/EDTA, PBS) are 
10 
connected to an inlet selection valve. The inlet selection valve 
is in turn connected to a miniature peristaltic pump (InstechTM 
OEM P625), which supplies medium to the zone inlet of each 
zone of the chamber. The zone outlets are connected to an 
15 outlet selection valve. The outlet selection valve is connected 
to a sample reservoir and a waste bag, and the flow from the 
zones are directed to either the sample reservoir or the waste 
bag as required by the operator or the computer software. 
Fluid dynamic manipulations are used to provide control 
20 over the cell culture environment within the device including 
medium infusion, selective cell removal, and establishment 
of chemical gradient and/or physical gradient. The inlet selec-
tion-valve permits different combinations of fluid reagents to 
enter the inlet ports of the zones of the culture chamber, while 
25 a outlet selection-valve guides the exiting fluid to a waste bag 
or sample reservoir. The pressure driven flow inside the zones 
of the culture chamber is controlled via a miniature peristaltic 
pump. Gas exchange is achieved via a gas permeable mem-
brane between the culture chamber and a gas chamber dis- 
30 posed above the membrane. Temperature is maintained exter-
nally with a Peltier element and a PID controller. Glass 
windows are strategically placed to enable phase-contrast and 
fluorescent morphological studies using inverted micro-
scopes. Protocols for the bioreactor processes are described 
35 herein. 
Characterization of the Bioreactor Flow Regime 
Characterization of the hydrodynamic environment in 
bioreactors is essential for the evaluation of vessel perfor-
mance. Proper fluidization, low shear stress, and adequate 
40 mass transport of nutrients are all characteristics of a well-
designed culture chamber. A numerical model was developed 
in FLUENTTM to evaluate these critical parameters in the 
design of the cell culture chamber. 
The three-dimensional bioreactor domain was discretized 
45 into a finite number of small control volumes using a com-
mercial mesh generator, GambitTM. The computational fluid 
dynamics package, FLUENTTM, was employed to compare 
analytical estimates. The fully developed, steady-state, lami-
nar flow field in the bioreactor is found by solving the equa- 
50 tions of conservation of mass and momentum. Numerical 
investigations were performed to evaluate the bioreactor's 
capability to perform selective cell removal, generate a 
chemical gradient, and evaluate fluid shear levels under typi-
cal working conditions. 
55 	 Selective Cell Removal 
Referring now to FIG. 10A, a computer generated simula-
tion 1000 of an initial flow of fluid into a zone 1002a of a two 
zone chamber 1004 such as the chamber 200 of FIG. 2A is 
shown, where the initial fluid front as fluid containing cells for 
60 seeding enters the zone 1002a, while zone 1002b is left unaf-
fected. During the initial inoculation of the zone 1002a with 
cells 1006 (here adhesive cells), the cells 1006 and anchorage 
proteins 1008 are randomly distributed within the zone 1002a 
as shown in FIG. 10B. After proliferation, the cells 1006 for a 
65 monolayer 1010 attached to a conducive substrate 1012 in the 
chamber 1004 by a protein anchorage layer 1014 as shown in 
FIG. 10C. 
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because the flow rates required to sustain the miniature 
culture are small, the Reynolds number is very low and flow 
in the central channel or in each zone possesses classic Hele-
Slaw flow characteristics. The flow in the zones 1002a&b of 
the chamber 1004 is essentially a two-dimensional laminar 
flow created by the thin channel and low fluid velocity con-
ditions. Laminar flow is characterized by fluid traveling in 
layers, where each element travels smoothly along simple, 
well-defined paths. This characteristic is exploited in anchor-
age dependent cultures to harvest cells from specific regions 
1002a or 1002b of the chamber 1004 for analysis without 
disturbing cell in the other regions. FIG. 10D illustrates this 
phenomenon by depicting computer generated pathlines 
1016a&b of fluid flowing into, through and out of the two 
zones 1002a&b of the chamber 1004 (see also the chamber 
200 of FIG. 2A) under normal working conditions. Cells 
suspended in the medium will also follow these fluid path-
lines 1016a&b. This characteristic can also be exploited for 
selective treatment or co-culture inoculation for interface 
studies. 
Once a desired cell population within the zone 1002a is 
achieved, the cell population is removed from the zone 1002a 
as illustrated in a simulation the miniature bioreactor as 
shown in FIG. 10D. A user-defined-scalar was defined in 
FLUENTTM to mimic the scalar transport of enzyme disso-
ciation solution Trypsin/EDTA (Trypsin-ethylene-diamine 
tetraacetic acid). FIG. 10D can be used to illustrate the 
removal of cells from the area 1002a in the chamber 1004 
growing on a glass slip at the base of the chamber 1004 (see 
FIG. 213). The flow rates in both inlets 1018a&b and out off 
both outlets 1020a&b are identical (M 1 _M2_ 1.166x10-6 
Kg/s). In FIG. 10D, the pathlines 1016a represent a defined 
scalar concentration value for Trypsin in the medium flowing 
in the zone 1002a, while the pathlines 1016b represent a 
defined scalar concentration value for medium flowing in the 
zone 1002b. As shown in FIG. 10D, medium infuses in the 
bottom inlet 1018a and travel along the pathlines 1016a 
towards the bottom outlet 1020a. If the top zone 1002b is also 
being harvested, then the Trypsin/EDTA will flow in a similar 
manner along the pathlines 1016b in the zone 1002b. After 
infusion, the pump wouldbe switched off to allow time for the 
enzymatic dissociation to occur in the region 1002a (approxi-
mately 3-5 minutes). During this process, Trypsin cleaves 
anchorage proteins 1008 , while EDTA encourages cells 1006 
to round up and internalize any other anchorage proteins 
1008. As the enzyme solution works, cells 1006 will dissoci-
ate from the growth substrate 1012 and become suspended in 
the media (the reverse of the process illustrated in FIGS. 
1OB&C). Upon subsequent infusion of fresh media, the cells 
1006 will be harvested from the treated region 1002a. A 
selection valve on the outlet side of the chamber 1004 will 
direct the harvested cells to a sample port and the spent 
medium to a waste reservoir. Cycling of the above procedures 
between the upper 1002b and lower 1002a zones enables the 
use of the culture chamber 1004 for long term studies of 
anchorage dependent cells. Suspension cells may also be 
cultured in the same device and sampled and/or harvested 
periodically simply by the infusion of new media. Efforts are 
generally required to redistribute cells away from the outlet 
after harvesting for efficient re-population. 
Generation of Chemical Gradients 
Although designed for selective cell removal, the geometry 
of the miniature bioreactor chamber and the fluid handling 
system make it ideal to study the effects of a known chemoat-
tractant on the cell migration (chemotaxis). To model the 
development of a chemical gradient, a second user-defined-
scalar was defined in FLUENTTM to mimic the scalar trans- 
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port of a common chemoattractant into and through the zones. 
The scalarprofiles are identical to those depicted in FIG. 10D, 
if the scalar Trypsin is replacedby some known chemoattrac-
tant. If chemotaxis is positive, cells will crawl in the direction 
5 perpendicular to the flow of reagent. In these problems, the 
Schmidt number, S c—v/D, may be used to characterize the 
ratio of momentum to mass diffusivity in the bioreactor, 
where v is the kinematic viscosity and D is the mass diffusiv-
ity. The Schmidt number for this case is large, S ~-1000, and 
10 hence the momentum diffusivity will be the prime driver for 
the distribution of the chemical constituent generating a steep 
gradient of the scalar normal to the centerline of the bioreac-
tor as predicted by the numerical model. 
15 	 Referring now to FIG. 11A-C, simulations 1100a-c are 
designed to demonstrate selective cell removal and contours 
of a scalar transport in 1102a of a two zone chamber 1104 of 
a bioreactor apparatus of this invention. In FIG. 11A-C, the 
scalar transport is characterized by: 
20 QTOT-0.14 mL/min. 
Ml—M2-1.166x 10-6 Kg/s 
scalar values between scalar _value, —0 to scalar_value2_1 
FIG. 11A shows the flow profile at t=1 s; FIG. 11B shows 
the flow profile at t=1 50s; and FIG. 11C shows the flow profile 
25 as the profile hits the outlet 1120a. 
Fluid Shear Levels 
Quantifying shear stress levels in the zone 1100a is a 
significant element in evaluating the efficacy of the mamma-
lian cell culture device and demonstrating its capabilities. 
30 Mammalian cells do not possess a cell wall; they are sur-
rounded by a thin plasma membrane. As a result, they are 
highly sensitive to shear stresses imposed on them by their 
environment. Goodwin et al. (1993) [1] found that stress 
levels as low at 0.92 dynes/cm 2 adversely affected the growth 
35 of baby hamster kidney (BHK) cells. An estimate of the shear 
level can be obtained by assuming flow between parallel 
plates. The velocity profile is given by Equation (1): 
40 	 umx =(,_(h)2) 
	 (1) 
where a is the fluid velocity at some height y in the zone 
45 1100a bioreactor, u m_ is the velocity along a centerline, and 
his the gap or height in the chamber (-2 mm). The shear stress 
at the wall of the zone 1102a is given by Equation (2): 
50 du 	 (2) 
T — 
_ 11TY 
â12 
where µ is the dynamic viscosity of the fluid media. Hence, 
fluid shear levels on a cell monolayer cultured in the zone 
55 1102a can be approximated by Equation (3): 
_ 4u'uma= _ 4u 3 	 6u'uavg 	 (3) 
h 	 h (2 ""g ~ — h 
60 
This approximation was first acknowledged by Levesque and 
Nerem (1985) [2]. FIGS. 11A and 11B illustrate contours of 
wall shear stress under typical working conditions calculated 
65 by the numerical model described above. The contours in 
FIG. 12A illustrate that the shear levels are less than 0.005 
dyne/cm2 under normal operating conditions. The contours in 
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FIG. 12B reveal slightly higher fluid shear levels (0.075 dyne/ 
cm2), but the flow rate is substantially higher (3.9 mL/min). 
These numerical findings correspond well with the analytical 
prediction above. Hence, the miniature bioreactor system can 
be used effectively as a low shear, fed batch culture device. 
Referring now to FIGS.I2A&B, the contours of wall shear 
stress (dyne/cm2). The greys colors are representative of wall 
shear stress levels (white low, grey intermediate). In FIG. 
12A, the wall shear stress levels at M 1=M2 1.166x10-6 Kg/s. 
Q-0.14 ml/min; and ti_g-0.005 dyne/cm2 . In FIG. 1213, the 
wall shear stress levels at M 1=M2- 3.25x10-s Kg/s; Q=3.9 
ml/min; and ti_g-0.075 dyne/cm2 . 
Materials and Methods 
Reagents and Solutions 
Dulbecco's modified eagle's medium (DMEM; with 25 
mM glucose and 4 mM glutamine), Hyclone fetal bovine 
serum (FBS), Sigma Trypsin-ethylene-diamine tetraacetic 
acid (EDTA), phosphate buffered saline (PBS), and Gibo 
penicillin-streptomycin solutions were all provided by 
(NASA/JSC). BHK-21 fibroblast culture medium for experi-
ments consisted of DMEM supplemented with 10% (v/v) of 
FBS and 1% (v/v) penicillin-streptomycin. 
BHK-21 Fibroblast Culture 
BHK-21 cells were provided by NASA, JSC. The fibro-
blasts were cultured at 37° C. in a 25 cm 2 tissue culture flasks 
(Sigma-Aldrich) in a humidified atmosphere supplemented 
with 5% CO 2 . Typically the cells were grown to confluence 
and passaged by trypsinization in 1 x Trypsin-EDTA solution. 
The cell suspension was diluted 5:1 with fibroblast culture 
medium and centrifuged at 3000 rpm for 1 minute. After 
aspiration of the supernatant, the pellet was resuspended in 
fibroblast culture medium and approximately 1 x10 5 or 5x105 
cells were inoculated into each fresh bioreactor system 
depending on desired inoculation level. 
Microchip Device 
The bioreactor of this invention can be integrated into a 
micro-fluid apparatus such as a cytometry microchip. In such 
a configuration, an effluent from the bioreactor including 
harvested cells or cell products is forwarded to a cytometry 
microchip illustrated in FIG. 13. A glass microchips was 
fabricated at the Culbertson laboratory at KSU using standard 
photolithographic and wet chemical etching techniques pre-
viously described by Jacobson et al. 1994[3]. The channels on 
the microchip are 27 µm wide and 100 M deep (flow 
through). All channel widths were measured at half-depth. 
Reservoirs were bonded to the chip via epoxy. 
Microfluidics Cytometry Signal Detection 
Harvested cells were fluorescently labeled with Calcein 
AM (Invitrogen, Molecular Probes, excitation/emission max 
-494 & 517 mu) and detected as they pass through a blue (488 
mu) solid state diode pumped crystal laser light beam. The 
laser light was focused on the channel in the microchip below 
the channel cross. Fluorescence emission was collected with 
a 40x objective and focused on an adjustable spatial filter. The 
signal was captured via a photomultiplier tube (PMT; 77348; 
Oriel) fashioned with an additional 1 mm spatial filter to 
reduce spurious noise. 
EXPERIMENTS OF THE INVENTION 
Miniature Bioreactor Preparation Inoculation 
The miniature bioreactor and fluid handling system was 
assembled in a biosaftey cabinet and rinsed with 70% isopro-
panol followed by a PBS/antibiotic flush (5% (v/v) penicillin-
streptomycin). The entire system was then autoclaved at 80° 
C. for several hours. Supplemented DMEM, Trypsin/EDTA, 
and a PBS/antibiotic solution were introduced into the correct 
reservoirs. A second PBS/antibiotic flush was performed to 
ensure all the isopropanol was removed and the system was 
purged of air. DMEM was then infused into the bioreactor and 
the system was allowed to reach 37° C. Recently harvested 
5 cells were siphoned into a syringe. The syringe was attached 
to the inoculation port and its contents were injected slowly 
into the system as the pump was running to infuse cells into 
the bioreactor. Since the cells are typically cultured in media 
with the phenol red, cell inoculation was monitored color- 
io metrically. The cells were allowed to attach to the growth 
surface before fresh media (with phenol red) was infused. 
Results & Discussion 
Once cells reached desired confluence, cell harvesting pro-
tocols described above were initiated. One half of the culture 
15 was washed with a saline solution and then treated with an 
enzyme solution for dissociation from the substrate, while the 
other half was flushed with cell media solution. FIGS. 
14A&B is a display of photomicrographs taken before (A) 
and after (B) a selective cell harvest inside the bioreactor. In 
20 some cases cells along the midline of the bioreactor would 
roll up due to the gradient of Trypsin/EDTA normal to the 
fluid interface. This did not seem to be an issue for long term 
cell culture. Cells recovered, laid back down, and began to 
migrate and repopulate the harvested region a few hours after 
25 the selective harvest. Residual extracellular matrix is believed 
to aid in cell recovery and repopulation. Cell number charac-
terization studies were performed as aresult of the integration 
of the miniature bioreactor system with a microfluidics 
cytometry platform. Verification of cell counts was achieved 
30 through comparison with hemocytometer counts and Via-
Count (Guava PCA) assays. Cells were inoculated in the 
bioreactor with 1x105 cells and allowed to reach approxi-
mately 80% confluence. Media was sampled and exchanged 
daily. Cells were harvested using trypsinization beginning on 
35 day 4. Approximately 1-3x105 cells were sampled each time 
as verified by three cytometry methods as shown in FIG. 15. 
The results demonstrate good repeatability in cell removal 
numbers and the ability for the cell culture device to repopu-
late in a timely fashion for long term cell culture sampling 
40 (-48 hours). 
Referring now to FIG. 16, a microphotograph of the har-
vested zone after 7 hours of migration and re-population of 
cells into the harvested zone. This migration and repopulation 
is evidence that the bioreactors of this invention can be used 
45 for moderate and long term culture, where cell are harvested 
on a continuous, semi-continuous, or periodic (preferred) to 
support moderate and long cultures while avoiding overpopu-
lation problems. 
Hypoxia Studies of Fetal Canine Cardiomyocyte 
50 	 The bioreactor of FIG. 8 was used to study the effects of 
hypoxia on fetal cardiomyocytes before and after the injec-
tion of stem cells. The study involved 24 hour hypoxia treat-
ments followed by 24 hour re-oxygenation treatments. Once 
cells in the zones were characterized, stem cells are injected 
55 into a stable fetal cardiomyocytes to study paracrine effects, 
stem cell differentiation and where the stem cells lower apo-
ptotic/necrotic levels. The study also tested stem cell super-
natant for paracrine effects. 
Experimental Procedures 
60 	 The experiments included inoculating the zones of the 
chamber of the bioreactor with fetal canine cardiomyocytes at 
about X=5x104 cells. The cells were then supplied with 
IMDM medium with 10% FBS and 1% antibiotics. Gas com-
positions were introduced into the medium feeding the zones. 
65 One gas composition was a normal oxygenation gas mixture 
including 95% air and 5% CO2 supplied from a first gas 
cylinder containing the gas mixture. To induce hypoxia, a gas 
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mixture including 95% Nitrogen and 5% CO 2 is used, which 
is supplied from a second gas cylinder. 
The experimental protocol includes normal culture prolif-
eration for 24 hours followed by photographs to result in cell 
characterization. After the normal culturing, one of the zones 
was exposed to hypoxic conditions for 24 hours and photo-
graphed. After hypoxic treatment, the hypoxic cells are re-
oxygenated for 24 hours and photographed. The cells were 
then in situ stained for morphological studies. The staining 
method included ethidium bromide (EB) and acridine orange 
(AO) in IMDM medium at 0.2 µM levels. 
Fetal cardiomyocytes were inoculated into both of the 
zones of the chamber of the bioreactor. Hypoxia was induced 
in one of the zones by introducing a gas mixture of 95% 
nitrogen and 5% carbon dioxide, while the other zone was 
exposed to a standard oxygen rich gas mixture of 95% oxygen 
and 5% carbon dioxide. The hypoxia introduction permeates 
the chamber as shown in FIG. 17, where the lower zone 
evidences the simulated concentration gradient front for 
hypoxia induction in the lower zone, with little exposure of 
the control zone on top. 
Referring now to FIGS. 18A-F, a series of microphoto-
graphs showing the proliferation of fetal cardiomyocytes 
cells in the zone of the chamber of the bioreactor of FIG. 8. 
The photographs clearly show that after 72 hours of culturing 
in the bioreactor, the zones are well populated with the fetal 
cardiomyocytes. All photo-micrographs were captured using 
a Nikon TMS phase contrast microscope. 
Referring now to FIG. 19A, a dye assay of live fetal cardi-
omyocytes shows well organized nuclei evidenced by the 
signature green fluorescence from acridine orange (AO) 
staining viewed through a 490/503,640/13,I13 filter. 
Referring now to FIG. 19B, a dye assay of apopotic cells or 
necrotic cells shows no cellular structures evidenced by no 
signature fluorescence from ethidium bromide (EB) staining 
viewed through a 545/605/G,IG filter. 
Referring now to FIG. 20A, an image of cells in a zone after 
24 hours of hypoxia treatment and 24 hours of re-oxygen-
ation. The image shows the presence of live cells with well 
defined nuclei as evidenced by the fluorescence from the 
acridine orange (AO) stained cells. Looking at FIG. 20B, an 
image of the same area using the ethidium bromide (EB) filter 
showing dead cells, which appear red in the image. Again, the 
image is of the cells in the zone after 24 hours of hypoxia 
treatment and 24 hours of re-oxygenation. Looking at FIG. 
20C, a merged image of the images of FIGS. 20A&B. This 
merged image shows that live cells and dead cells. Looking at 
FIG. 20D, a cell quantification analysis is shown based on the 
merged image. 
Referring now to FIGS. 21A&B, two cell quantifications 
are shown after 24 hour hypoxia treatment, one analysis rep-
resents a cell quantification in the normal region and one 
analysis represents a cell quantification in the hypoxia region. 
Graphs of percentage of total cells from photomicrographs 
(n3) of live, dead, and apoptotic cells after 24 hours of 
hypoxia treatment in the hypoxia region. Error bars are 
experimental values given as mean and SEM. Since the exp. 
set is small a student t test is employed for correction. 
Referring now to FIGS. 22A&B, two cell quantifications 
are shown after 24 hour re-oxygenation treatment of the cul-
tures of FIGS. 21A&B, one analysis represents a cell quan-
tification in the normal region and one analysis represents a 
cell quantification in the re-oxygenation of the hypoxia 
treated region. Graphs of % of total cells from photomicro-
graphs (n=3) of live, dead, and apoptotic cells after 24 hours 
ofreoxygenation. Error bars are experimental values given as 
28 
mean and SEM. Since the experimental set is small a student 
t test is employed for correction. 
Referring now to FIG. 23, shows the growth rate of fetal 
canine cardiomyocytes in the presence ofAO & EB showing 
5 that the two dye treatments have little affect on normal cell 
proliferation as compared to the control. 
The hypoxia studied set forth above demonstrates that the 
bioreactors of this invention are ideal for simulating short, 
moderate and long term effects of hypoxia or the effects of 
io other conditions that subject cells to a stress. Because the 
cultures can be exposed to conditions that are similar to what 
heart tissue may experience during a myocardial infarction, 
then the bioreactor can be used to study treatment options, 
such as stem cell inoculation to the hypoxic region (a region 
15 after hypoxia treatment). Thus, fetal myocardial cell are 
inoculated into two zone of the chamber of a bioreactor of 
FIG. 8 and hypoxia is induced into one zone by introducing a 
gas composition to the zone to starve the zone of oxygen. 
Because the other zone is being feed an oxygen rich gas 
20 composition, some gas exchange from one zone to the other 
zone may occur, but such is similar to what actually transpires 
in the heart. After hypoxia treatment, stem cells can be intro-
duced into the hypoxia treated zone or into both zones. The 
effects of the stem cell introduction can be monitoring visu- 
25 ally using a light microscope, using active dyes, or analyzing 
cell products. Stem cell introduction follows the same pattern 
as shown in FIG. 17. 
30 
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Although the invention has been disclosed with reference to 
its preferred embodiments, from reading this description 
those of skill in the art may appreciate changes and modifi-
cation that may be made which do not depart from the scope 
50 and spirit of the invention as described above and claimed 
hereafter. 
We claim: 
1. An apparatus for growing cells comprising: 
55 	 a laminar flow chamber including: 
a plurality of inlets disposed in a first end of the chamber, 
where each inlet includes a diffuser, and 
a corresponding plurality of outlets disposed in a second 
end of the chamber, where each outlet includes a 
60 	 collector, 
where the inlets on the first end of the chamber are aligned 
with the outlets on the second end of the chamber, where 
fluid flowing through the inlets establishes substantially 
separated, parallel laminar flow zones within the cham- 
65 ber between the inlets and the aligned outlets, and where 
the chamber includes no physical barriers separating the 
laminar flow zones, 
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a fluid handling system including: 	 an outlet having: 
a liquid handling subsystem including: 	 a collector; 
at least one inlet valve, and 	 a fluid handling system including: 
at least one outlet valve, 	 a liquid handling subsystem adapted to supply a 
	
where the at least one inlet valve is connected to the 5 	 medium to the zones and including: 
	
chamber inlets for supplying medium to the zones 	 at least one inlet valve, and 
	
of the chamber and the at least one outlet valve is 	 at least one outlet valve; 
	
connected to the chamber outlets directing spent 	 a medium reservoir connected to the at least one inlet 
	
fluid from the zones to a waste container, a cell 	 valve; 
	
collecting container, or a medium recycle conduit a 10 	 a harvesting agent reservoir connected to the at least one 
	
gas permeable membrane forming a top surface or 	 inlet valve; 
bottom surface of the zones, 	 an additive reservoir connected to the at least one inlet 
	
a controlled gas chamber assembly disposed above the top 	 valve; 
surface or below the bottom surface including: 	 a waste container connected to the at least one inlet 
side walls, 	 15 	 valve; 
a gas impermeable top, 	 a cell collecting container connected to the at least one 
an open bottom, 	 inlet valve; 
	
a gas chamber defined by the wall, the top and the 	 optional medium recycle conduit connected to the at 
permeable membrane of the zones, 	 least one inlet valve; 
a gas inlet connected to a gas supply and 	 20 	 a gas handling subsystem adapted to supply gas to the 
a gas outlet connected to a vent, 	 zones and including: 
	
where the assembly is adapted to circulate a gas compo- 	 a gas permeable membrane forming a top surface or 
	
sition into the chamber through the inlet and out of the 	 bottom surface of the zones, 
	
outlet at a rate sufficient to permit the gas composition 	 a controlled gas chamber assembly disposed above 
	
to be transported into the zones and exchanged from 25 	 the top surface or below the bottom surface 
the zones, and 
	
including: 
a gas handling subsystem having: 	 side walls, 
gas supply, 	 a gas impermeable top, 
at least one inlet valve, and 	 an open bottom, 
gas regulator, 	 30 	 a gas chamber defined by the wall, the top and 
	
where the gas handling subsystem supplies gas at a 	 the permeable membrane of the zones, 
controlled rate to the gas chamber. 	 a gas inlet connected to a gas supply and 
2. The apparatus of claim 1, wherein each zone includes: 	 a gas outlet connected to a vent, 
a substrate disposed on a top or bottom of the zone. 	 where the assembly is adapted to circulate a gas 
3. The apparatus of claim 2, wherein the substrate is a cell 35 	 composition into the chamber through the inlet 
conducive substrate. 	 and out of the outlet at a rate sufficient to permit 
4. The apparatus of claim 2, wherein the substrate is trans- 	 the gas composition to be transported into the 
	
parent to light of a desired region of the electromagnetic 	 zones and exchanged from the zones; 
spectrum. 	 inoculating each zone of the chamber with the same or 
5. The apparatus of claim 1, wherein the gas handling 40 	 different cells; 
subsystem includes: 	 growing the inoculated cells to a desired population in each 
	
a gas in-line introduction subsystem including at least one 	 zone, where the desired cell population is the same or 
	
bubble trap and at least one gas exchanger adapted to 	 different; 
	
introduce a gas composition directly into the medium 	 harvesting a portion of the cell population in each of the 
before the medium enters the inlets of the chamber. 	 45 	 zone, when the cells in the zone have grown to its desired 
6. The apparatus of claim 5, wherein the gas in-line intro- 	 cell population; and 
duction subsystem includes: 	 collecting the harvested cells. 
a bubble trap for each zone and 
	
10. The method of claim 9, wherein the harvesting step 
a gas exchanger for each zone. 	 includes the steps of: 
7. The apparatus of claim 1, further comprising: 	 50 	 washing the zone to be harvested with saline solution; 
	
a medium reservoir connected to the at least one inlet valve, 	 flushing the zone to be harvested with an enzyme treatment 
	
a harvesting agent reservoir connected to the at least one 	 to prepare the cells for harvesting; and 
inlet valve, and 
	
infusing fresh medium into the zone to be harvested, 
	
an additive reservoir connected to the at least one inlet 	 where the enzyme treated cells, which are now suspended 
valve, 	 55 	 in the medium in the zone, are wept from the zone for 
	
where the reservoirs are adapted to supply medium to the 	 collecting in the collecting step. 
	
zones for feeding, harvesting or stressing the cells in the 	 11. The method of claim 9, further comprising the step of: 
zones. 	 allowing a remaining cell population to migrate throughout 
8. The apparatus of claim 1, wherein the cells are selected 	 the harvested zone, and 
	
from the group consisting of prokaryotic cells, eukaryotic 60 	 repeating the growing, harvesting and collecting steps 
cells, stem cells, and mixtures or combinations thereof. 	 every time the cell population reaches the same or dif- 
9. A method of culturing cells comprising the steps of: 	 ferent desired population. 
providing a laminar flow bioreactor comprising: 	 12. The method of claim 11, wherein the harvesting step 
a laminar flow chamber including: 	 includes the steps of: 
	
a plurality of laminar flow zones, each zone including: 65 	 washing the zone to be harvested with saline solution; 
an inlet having: 	 flushing the zone to be harvested with an enzyme treatment 
a diffuser, and 	 to prepare the cells for harvesting; and 
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infusing fresh medium into the zone to be harvested, 
where the enzyme treated cells, which are now suspended 
in the medium in the zone, are wept from the zone for 
collecting in the collecting step. 
13. A method of culturing cells comprising the steps of: 
providing a laminar flow bioreactor comprising: 
a laminar flow chamber including: 
a plurality of laminar flow zones, each zone including: 
an inlet having: 
a diffuser, and 
an outlet having: 
a collector, 
a fluid handling system including: 
a liquid handling subsystem adapted to supply a 
medium to the zones and including: 
at least one inlet valve and 
at least one outlet valve, 
a medium reservoir connected to the at least one inlet 
valve; 
a harvesting agent reservoir connected to the at least one 
inlet valve; 
an additive reservoir connected to the at least one inlet 
valve; 
a waste container connected to the at least one inlet 
valve; 
a cell collecting container connected to the at least one 
inlet valve; 
32 
optional medium recycle conduit connected to the at 
least one inlet valve; 
a gas handling subsystem adapted to supply gas to the 
zones and including: 
5 	 a gas in-line introduction subsystem comprising: 
a bubble trap for each zone, and 
a gas exchanger for each zone; 
where the bubble traps are adapted to introduce a gas 
composition into the medium, and the gas exchangers 
io 	
are adapted to permit gas exchange in the medium. 
inoculating each zone of the chamber with the same or 
different cells, 
growing the inoculated cells to a desired population in each 
zone, where the desired cell population is the same or is 	 different, 
harvesting a portion of the cell population in each of the 
zone, when the cells in the zone have grown to its desired 
cell population, and 
collecting the harvested cells. 
~~ 	 14. The method of claim 13, further comprising the step of: 
allowing a remaining cell population to migrate throughout 
the harvested zone, and 
repeating the growing, harvesting and collecting steps 
every time the cell population reaches the same or dif-
ferent desired population. 
